Skip to content
Menu

Guggenheim Assumes Tyra Biosciences at Buy, Announces Price Target of $55

Benzinga Newsdesk 1 day ago

Analyst RatingsNewsInitiationPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Guggenheim analyst Debjit Chattopadhyay assumes Tyra Biosciences (NASDAQ:TYRA) with a Buy rating and announces Price Target of $55.

Guggenheim analyst Debjit Chattopadhyay assumes Tyra Biosciences (NASDAQ:TYRA) with a Buy rating and announces Price Target of $55.

Read at benzinga.com

← All stock news